Skip to main content

Market Overview

Intercept Prices 1.5M Share Offering at $62.50/Share


Intercept Pharmaceuticals (NASDAQ: ICPT) announced Tuesday the pricing of an underwritten public offering of 1,500,000 shares of its common stock by certain selling stockholders at a public offering price of $62.50 per share.  In addition, the selling stockholders have granted the underwriters a 30-day option to purchase up to an additional 225,000 shares of common stock.

All of the shares in the offering are to be sold by the selling stockholders.  Intercept will not receive any proceeds from the sale of the shares of common stock by the selling stockholders in the offering.  The offering is expected to close on or about October 15, 2013, subject to customary closing conditions. 

BofA Merrill Lynch is acting as the sole bookrunning manager and underwriter for the offering. 

See full press release


Related Articles (ICPT)

View Comments and Join the Discussion!

Posted-In: News Guidance Contracts Management Global

Need corporate guidance data?
Click here to see licensing options.
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at